Jefferies Group’s Insulet PODD Stock Holding History

Jefferies Group’s Portfolio PODD Stock Details PODD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-15,500	Closed	-$2.56M	–	2895
2019 Q3	$2.56M	Buy	+15,500	New	+$2.18M	0.02%	924

Other funds holding PODD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jefferies Group's PODD Position: Q2 2022 in Review

Jefferies Group sold out of Insulet (PODD) in Q2 2022, closing a stake of 838 shares — an estimated $223K sold.

Jefferies Group first reported a position in PODD in Q2 2013 and held it in 15 quarters. The position peaked at $5.27M in Q3 2019. 449 funds tracked by Wall St. Rank hold PODD as of Q2 2022.

Jefferies Group reported no remaining Insulet position as of Q2 2022 after selling out during the quarter.
Jefferies Group sold 838 Insulet shares in Q2 2022, an estimated $223K.
Jefferies Group first reported a position in Insulet in Q2 2013 and held it in 15 quarters.
Jefferies Group's Insulet position peaked at $5.27M in Q3 2019.
449 funds tracked by Wall St. Rank held Insulet as of Q2 2022.

Based on Jefferies Group's 13F filing for Q2 2022, filed 15 Aug 2022.